Fleming Harold Edward 🟢 acquired 13.0K shares (1 derivative) of CRISPR Therapeutics AG (CRSP) at $51.84 Transaction Date: Jun 05, 2026 | Filing ID: 264289
Director SHERWIN STEPHEN A 🟡 adjusted position in 25.0K shares (2 derivative) of NEUROCRINE BIOSCIENCES INC (NBIX) at $167.31 ($7.3M) Transaction Date: Jun 05, 2026 | Filing ID: 000006
Malik Fady Ibraham 🟡 adjusted position in 3.5K shares (1 derivative) of CYTOKINETICS INC (CYTK) at $67.98 Transaction Date: Jun 09, 2026 | Filing ID: 000067